Charles R Scoggins

Author PubWeight™ 120.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005 4.86
2 Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg 2012 2.93
3 Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique? Ann Surg 2011 2.87
4 Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg 2008 2.80
5 Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 2002 2.28
6 Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg 2014 2.15
7 Laparoscopic versus open hepatic resection for hepatocellular carcinoma: improvement in outcomes and similar cost. World J Surg 2015 2.10
8 Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 2009 1.97
9 Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol 2008 1.88
10 A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg 2010 1.83
11 Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer 2010 1.53
12 Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"? J Gastrointest Surg 2013 1.52
13 Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab. Ann Surg 2011 1.52
14 The use of self-expanding silicone stents in esophagectomy strictures: less cost and more efficiency. Ann Thorac Surg 2008 1.51
15 Assessment of mitotic rate reporting in melanoma. Am J Surg 2012 1.47
16 The lower incidence of melanoma in women may be related to increased preventative behaviors. Am J Surg 2010 1.45
17 Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009 1.44
18 An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg 2009 1.42
19 Factors associated with surgical options for breast carcinoma. Cancer 2006 1.34
20 Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 2009 1.23
21 Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Arch Surg 2009 1.20
22 Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg 2008 1.18
23 Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 2005 1.17
24 Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system. J Gastrointest Surg 2010 1.14
25 Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol 2009 1.10
26 A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients. Surgery 2008 1.08
27 Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol 2007 1.07
28 Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res 2009 1.06
29 Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery 2005 1.06
30 Laparoscopic hepatic lobectomy: advantages of a minimally invasive approach. J Am Coll Surg 2010 1.02
31 Microwave hepatic ablation: initial experience of safety and efficacy. J Surg Oncol 2007 1.02
32 Stroke volume variation in hepatic resection: a replacement for standard central venous pressure monitoring. Ann Surg Oncol 2013 1.02
33 Laparoscopic versus open resection of hepatic colorectal metastases. Surgery 2012 1.00
34 Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? J Am Coll Surg 2009 0.99
35 Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg 2011 0.99
36 Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling. Ann Surg Oncol 2013 0.98
37 Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol 2010 0.98
38 Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 2006 0.98
39 Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford) 2012 0.98
40 A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg 2008 0.98
41 Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. J Am Coll Surg 2011 0.98
42 A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol 2011 0.97
43 Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg 2010 0.96
44 Is incisional biopsy of melanoma harmful? Am J Surg 2005 0.94
45 Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll Surg 2009 0.94
46 Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg 2011 0.92
47 Second primary melanomas: incidence and outcome. Am Surg 2010 0.92
48 Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg 2011 0.90
49 Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J 2007 0.90
50 Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol 2011 0.89
51 The prognostic significance of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2010 0.88
52 Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg 2008 0.88
53 recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Ann Surg Oncol 2011 0.87
54 Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature. Am Surg 2008 0.87
55 A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol 2008 0.87
56 Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann Surg Oncol 2010 0.87
57 Are 3 sentinel nodes sufficient? Arch Surg 2007 0.86
58 The use of self-expanding silicone stents in esophageal cancer care: optimal pre-, peri-, and postoperative care. Surg Endosc 2008 0.86
59 Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry. Am Surg 2011 0.86
60 Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Am Surg 2011 0.86
61 Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial. J Gastrointest Surg 2012 0.86
62 Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg 2013 0.86
63 Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma. Ann Surg Oncol 2007 0.86
64 Lymphovascular invasion as a prognostic factor in melanoma. Am Surg 2011 0.86
65 Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma? Am J Surg 2010 0.85
66 Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma. Ann Surg Oncol 2014 0.85
67 Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg 2008 0.85
68 Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg 2010 0.84
69 Health-related quality of life: return to baseline after major and minor liver resection. Surgery 2007 0.84
70 Effect of multiple-nodal basin drainage on cutaneous melanoma. Arch Surg 2008 0.84
71 Body mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg 2007 0.84
72 A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg 2011 0.84
73 Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol 2011 0.84
74 Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg 2005 0.83
75 Surgeon and community factors affecting breast cancer sentinel lymph node biopsy. Am J Surg 2005 0.83
76 Differences between bipolar compression and ultrasonic devices for parenchymal transection during laparoscopic liver resection. HPB (Oxford) 2012 0.83
77 Impact of histology on survival in retroperitoneal sarcomas. Am J Surg 2011 0.83
78 Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? HPB (Oxford) 2010 0.83
79 Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer. J Surg Oncol 2013 0.82
80 Ablative therapies for colorectal liver metastases. Surg Oncol Clin N Am 2010 0.82
81 Unique prognostic factors in acral lentiginous melanoma. Am J Surg 2012 0.82
82 Clinicopathologic and survival differences between upper and lower extremity melanomas. Am Surg 2012 0.82
83 Biopsy type does not influence sentinel lymph node status. Am J Surg 2005 0.82
84 Retroperitoneal and visceral sarcomas: issues for the general surgeon. Am Surg 2007 0.82
85 Advances in the surgical management of liver malignancies. Cancer J 2004 0.82
86 Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation? Ann Surg Oncol 2009 0.81
87 Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients. Ann Surg 2014 0.81
88 Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg 2006 0.80
89 Bile cultures: a guide to infectious complications after pancreaticoduodenectomy. J Surg Oncol 2010 0.80
90 Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis. Am J Surg 2013 0.80
91 Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer. J Gastrointest Surg 2011 0.80
92 Do melanoma patients from Southern climates have a worse outcome than those from Northern climates? Am Surg 2009 0.80
93 Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer. Am Surg 2012 0.80
94 Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy? Am J Surg 2010 0.79
95 Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit? Surgery 2013 0.79
96 Surveillance after surgical treatment of melanoma: futility of routine chest radiography. Surgery 2010 0.79
97 Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Ann Surg Oncol 2012 0.79
98 Laparoscopic hepatectomy is a safe and effective approach for resecting large colorectal liver metastases. Am Surg 2013 0.79
99 The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty. Am J Surg 2008 0.78
100 Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. J Surg Res 2007 0.78
101 A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model. J Am Coll Surg 2012 0.78
102 Safety and efficacy of hepatectomy for colorectal metastases in the elderly. J Surg Oncol 2011 0.78
103 The evolution of the management of regional lymph nodes in melanoma. J Surg Oncol 2007 0.78
104 Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials. J Surg Oncol 2013 0.77
105 Negative effects of transfused blood components after hepatectomy for metastatic colorectal cancer. Am Surg 2013 0.77
106 Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicated? J Surg Res 2008 0.77
107 Proposed staging system for gastrointestinal carcinoid tumors. Am Surg 2008 0.77
108 Outcomes and prognostic factors in nodular melanomas. Surgery 2012 0.77
109 Kentucky hepatoma: epidemiologic variant or same problem in a different region? Arch Surg 2007 0.77
110 Preoperative performance status predicts outcome following heated intraperitoneal chemotherapy. Am J Surg 2008 0.76
111 Caudate lobe resections: a single-center experience and evaluation of factors predictive of outcomes. World J Surg Oncol 2013 0.76
112 Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients. Am Surg 2013 0.76
113 Impact of post-operative complications on quality of life after pancreatectomy. JOP 2012 0.75
114 More options and improved outcomes for hepatocellular carcinoma. J Surg Oncol 2008 0.75
115 Is wedge resection of hepatic colorectal cancer metastases an oncologically sound alternative? J Surg Oncol 2008 0.75
116 Esophageal carcinoma histology affects perioperative morbidity following open esophagogastrectomy. J Oncol 2009 0.75
117 Neoadjuvant therapy for soft tissue sarcomas: does it make a difference? Cancer 2008 0.75
118 Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma. J Am Coll Surg 2013 0.75
119 Ovarian mucinous cystadenoma as an etiology of the Zollinger-Ellison Syndrome. Surgery 2006 0.75
120 Soft tissue sarcoma of the extremity and trunk: issues for the general surgeon. Am Surg 2006 0.75
121 Prior biliary tree instrumentation does not preclude hepatic arterial therapy for malignancy. Am Surg 2010 0.75
122 Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why. J Ky Med Assoc 2009 0.75
123 A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy. J Surg Oncol 2006 0.75
124 Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium. Am Surg 2017 0.75
125 Esophageal anastomotic leak does not affect ability to receive adjuvant treatment. J Surg Oncol 2015 0.75
126 Surgical prophylaxis for inheritable malignant diseases: colorectal and gastric cancer. Am Surg 2009 0.75
127 Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg 2017 0.75
128 Outcomes and prognostic factors in superficial spreading melanoma. Am J Surg 2013 0.75
129 The lymph node ratio has limited prognostic significance in melanoma. J Surg Res 2012 0.75
130 Surgical prophylaxis for inheritable malignant diseases: breast cancer and endocrine disease. Am Surg 2009 0.75
131 Quality of survival reporting in chemotherapy and surgery trials in patients with metastatic colorectal carcinoma. Cancer 2006 0.75
132 Adequate lymphadenectomy results in accurate nodal staging without an increase in morbidity in patients with gastric adenocarcinoma. Am J Surg 2008 0.75